Roscovitine
(BTIHMVBBUGXLCJ-OAHLLOKOSA-N)
Structure
- SMILES
- CC[C@@H](Nc1nc(NCc2ccccc2)c2c(n1)n(cn2)C(C)C)CO
- Type(s)
- Investigational
- Molecular Formula:
- C19H26N6O
- Molecular Weight:
- 354.449
- Log P:
- 3.3481
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 3
- TPSA:
- 87.89
- CAS Number(s):
- 186692-46-6
Synonym(s)
1.
Roscovitine
2.
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
3.
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
4.
CYC 202
5.
CYC-202
6.
CYC202
7.
R-roscovitine
8.
Seliciclib
9.
R roscovitine
External Link(s)
| MeSH | D000077546 |
| PubChem Compound | 160355 |
| BindingDB | 7533 |
| ChEBI | 45307 |
| CHEMBL | CHEMBL14762 |
| DrugBank | DB06195 |
| IUPHAR/BPS Guide to PHARMACOLOGY | 6035 |
| Therapeutic Target Database | D02TIZ D05ADP |
| ZINC | 1649340 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dyskinesia, Drug-Induced | 20504213 | CTD | |
| 2 | Prostatic Neoplasms | 16140939 | CTD | |
| 3 | leukemia | 16275999 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.